SIC
WST icon

SJS Investment Consulting’s West Pharmaceutical WST Stock Holding History

SJS Investment Consulting’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.4K Sell
118
-6
-5% -$1.83K ﹤0.01% 525
2026
Q1 		$31.1K Sell
124
-58
-32% -$14.4K ﹤0.01% 541
2025
Q4 		$50.1K Buy
182
+46
+34% +$12.6K 0.01% 361
2025
Q3 		$35.7K Buy
136
+129
+1,843% +$31.4K ﹤0.01% 418
2025
Q2 		$1.53K Sell
7
-3
-30% -$641 ﹤0.01% 660
2025
Q1 		$2.24K Sell
10
-2
-17% -$551 ﹤0.01% 676
2024
Q4 		$3.93K Buy
12
+5
+71% +$1.57K ﹤0.01% 478
2024
Q3 		$2.1K Hold
7
– – ﹤0.01% 764
2024
Q2 		$2.31K Sell
7
-1
-13% -$353 ﹤0.01% 652
2024
Q1 		$3.17K Hold
8
– – ﹤0.01% 576
2023
Q4 		$2.82K Sell
8
-2
-20% -$708 ﹤0.01% 536
2023
Q3 		$3.75K Buy
10
+1
+11% +$387 ﹤0.01% 437
2023
Q2 		$3.44K Sell
9
-1
-10% -$357 ﹤0.01% 434
2023
Q1 		$3.47K Buy
10
+2
+25% +$584 ﹤0.01% 444
2022
Q4 		$1.88K Buy
8
+5
+167% +$1.19K ﹤0.01% 657
2022
Q3 		$1K Buy
+3
New +$914 ﹤0.01% 953
2022
Q1 		$2K Buy
+4
New +$1.57K ﹤0.01% 530

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

SJS Investment Consulting's WST Position: Q2 2026 in Review

SJS Investment Consulting reduced its West Pharmaceutical (WST) stake by 4.8% in Q2 2026, selling an estimated $1.83K and leaving 118 shares worth $42.4K. The position accounts for ﹤0.01% of the portfolio, ranked #525.

SJS Investment Consulting first reported a position in WST in Q1 2022 and has held it in 17 quarters since. The position peaked at $50.1K in Q4 2025. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • SJS Investment Consulting held 118 shares of West Pharmaceutical worth $42.4K as of Q2 2026.
  • SJS Investment Consulting sold 6 West Pharmaceutical shares in Q2 2026, an estimated $1.83K.
  • West Pharmaceutical made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #525 holding.
  • SJS Investment Consulting first reported a position in West Pharmaceutical in Q1 2022 and has held it in 17 quarters since.
  • SJS Investment Consulting's West Pharmaceutical position peaked at $50.1K in Q4 2025.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.